Typical antibody-based induction immunosuppression therapy uses antibody preparations directed at T cells in combination with calcineurin inhibitors, antiproliferative agents, and corticosteroids. Calcineurin inhibitors have been a cornerstone of clinical immunosuppression in transplantation since the early 1980s.
PD-1 inhibitors, tyrosine kinase inhibitors, and vascular endothelial growth factor receptor inhibitors are all types of immunotherapies used in the treatment of kidney cancer.
Learn more about immunosuppressive agents used for kidney transplantation.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ron Shapiro. Fast Five Quiz: Immunosuppression for Kidney Transplantation - Medscape - Oct 22, 2021.